⚕ GalenOps CRO console
← 713 (USA)

713-1043

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 713 (USA) (Dr. Kowalski) · consented 2013-09-15
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 12.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 12.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild CATARACT OPERATION — outcome: RECOVERED/RESOLVED; onset 2014-03-08 (study day 175.0); relationship: NONE

moderate assessed 2026-08-18

Moderate NAUSEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate VOMITING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.